Skip to main content
. 2018 Jul-Sep;10(3):134–140.

Table 1.

Classification of mice according to the injection substances

Groups under study according to the injection substance Total number of mice Number of mice of immunological evaluations (no challenging) Number of mice of immunological evaluations after challenging Number of mice of survival time, diameter of lesion and weight evaluations after challenging
PBS 15 5 5 5
pcDNA3 15 5 5 5
pCAGGS-IL12 15 5 5 5
pCAGGS-IL12 pcDNA3+ 15 5 5 5
pcLACK 24 8 8 8
pcLACK+ pcTSA+pCAGGS-IL12 24 8 8 8